Literature DB >> 3965933

Bronchiolitis obliterans organizing pneumonia.

G R Epler, T V Colby, T C McLoud, C B Carrington, E A Gaensler.   

Abstract

In 50 of 94 patients with bronchiolitis obliterans we found no apparent cause or associated disease, and the bronchiolitis obliterans occurred with patchy organizing pneumonia. Histologic characteristics included polypoid masses of granulation tissue in lumens of small airways, alveolar ducts, and some alveoli. The fibrosis was uniform in age, suggesting that all repair had begun at the same time. The distribution was patchy, with preservation of background architecture. Clinically, there was cough or flu-like illness for 4 to 10 weeks, and crackles were heard in the lungs of 68 per cent of the patients. Radiographs showed an unusual pattern of patchy densities with a "ground glass" appearance in 81 per cent. Physiologically, there was restriction in 72 per cent of the patients, and 86 per cent had impaired diffusing capacity. Obstruction was limited to smokers. The mean follow-up period was four years. With corticosteroids, there was complete clinical and physiologic recovery in 65 per cent of the subjects; two died from progressive disease. This disorder differs from bronchiolitis obliterans with irreversible obstruction. It was confused most often with idiopathic pulmonary fibrosis. In view of the benign course and therapeutic response, a histologic distinction is important.

Entities:  

Mesh:

Year:  1985        PMID: 3965933     DOI: 10.1056/NEJM198501173120304

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  123 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Systematic review of postradiotherapy bronchiolitis obliterans organizing pneumonia in women with breast cancer.

Authors:  Gary R Epler; Eileen M Kelly
Journal:  Oncologist       Date:  2014-10-31

3.  Chronic transmural bronchiolitis: a non-specific lesion of small airways.

Authors:  C Edwards; R Cayton; R Bryan
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

4.  Organising pneumonia as the first manifestation of rheumatoid arthritis.

Authors:  Chisho Hoshino; Noriyuki Satoh; Masashi Narita; Akio Kikuchi; Minoru Inoue
Journal:  BMJ Case Rep       Date:  2011-03-24

5.  Organising pneumonia presenting as acute life threatening pulmonary haemorrhage.

Authors:  Damodhara Honnavally Narasimhaiah; Indranil Chakravorty; Rajiv Swamy; Doraiswamy Prakash
Journal:  BMJ Case Rep       Date:  2011-11-08

6.  The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis.

Authors:  C Kuhn; J A McDonald
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

7.  Clinicopathological study of migratory lung infiltrates.

Authors:  Y Miyagawa; N Nagata; N Shigematsu
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

8.  Nonhomogeneous density of CD34 and VCAM-1 alveolar capillaries in major types of idiopathic interstitial pneumonia.

Authors:  Edwin Roger Parra; Ligia Rodrigues Silvério da Costa; Alexandre Ab'Saber; Carlos Roberto Ribeiro de Carvalho; Ronaldo Adib Kairalla; Sandra Moraes Fernezlian; Lisete R Teixeira; Vera Luiza Capelozzi
Journal:  Lung       Date:  2005 Sep-Oct       Impact factor: 2.584

9.  Bronchiolitis obliterans organizing pneumonia simulating progression in bronchioloalveolar carcinoma.

Authors:  Manuel Cobo Dols; Silvia Gil Calle; Immaculada Alés Díaz; Ester Villar Chamorro; Julia Alcaide García; Vanesa Gutiérrez Calderón; Manuel Benavides Orgaz
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

10.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.